Use of potent inhalational anesthetic agents during mechanical ventilation
Pediatric and Neonatal Mechanical Ventilation: From Basics to Clinical Practice, Page: 863-885
2015
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures2
- Readers2
Book Chapter Description
The clinical practice of inhalational anesthesia began in the 1840s with the demonstration of the efficacy of diethyl ether by Crawford Long and WTG Morton and nitrous oxide (NO) by Horace Wells. In 1946, Robbins reported the development of various fluorinated hydrocarbons (Robbins 1946). This work led to the synthesis in 1951 of fluroxene (2,2,2-trifluoroethyl vinyl ether), a fluorinated hydrocarbon, which was the first of this class of agents to be widely used in clinical practice (Krantz et al. 1953; Tucker et al. 1973; Johnston et al. 1973; Harris and Cromwell 1972). Halothane, a halogenated alkane, was introduced into clinical practice in 1956 (Raventos 1956). When compared with its predecessors, halothane offered several favorable properties including nonflammability, a favorable blood-gas partition coefficient, a favorable profile for inhalation induction including a rapid onset and limited pungency, bronchodilatation, relative cardiovascular stability, and a decreased incidence of nausea and vomiting. However, halothane’s potential to elicit an immune-mediated hepatotoxicity especially in the adult population favored the development of additional agents with less hepatotoxicity.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84944537481&origin=inward; http://dx.doi.org/10.1007/978-3-642-01219-8_31; https://link.springer.com/10.1007/978-3-642-01219-8_31; https://dx.doi.org/10.1007/978-3-642-01219-8_31; https://link.springer.com/chapter/10.1007/978-3-642-01219-8_31
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know